Delivery Order SPE2DR25D2014-SPE2DR26FZ62D
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Myrbetriq ER 25 mg tablets (90-count) with a ceiling value of $20,903.91. This firm fixed-price delivery order, with an ultimate completion date of October 28, 2025, was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where the company maintains operations as one of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Myrbetriq ER 25 mg tablets (30-count units) valued at $1,549.42. This is a firm fixed price delivery order with no set-aside designation, representing a competitive award to the pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count) with a ceiling value of $1,510.27. This is a firm fixed-price delivery order with an ultimate completion date of December 1, 2025, and does not carry a set-aside designation, indicating it was awarded through open competition. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $2,780.85 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 13, 2025, for the supply of Myrbetriq ER 25 mg tablets (90-count units). This is a non-set-aside competitive award with an ultimate completion date of December 15, 2025, and performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Myrbetriq ER 25 mg tablets (90-count units) valued at $10,076.28. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by August 13, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order through its corporate office...
- The Defense Logistics Agency awarded a $2,492.95 firm fixed price delivery order to AmerisourceBergen Drug Corp for Myrbetriq ER 25 mg tablets (90-count supply) on December 9, 2025, with completion scheduled for December 10, 2025. This non-competitive delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026. AmerisourceBergen, a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Myrbetriq ER 25 mg tablets (90-count units) with a ceiling value of $1,210.02. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Myrbetriq ER 50 mg tablets (30-count packages) with a contract value of $9,750.53. This is a firm fixed-price delivery order with no set-aside designation, completed competitively through open procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract has an ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Myrbetriq ER 25 mg tablets (90-count units) with a ceiling value of $17,143.18. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 28, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count packaging) valued at $24,907.29. This firm fixed-price delivery order, with completion targeted for November 7, 2025, represents a non-competitive award under an existing contract vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania, supporting federal medical...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ62DDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Myrbetriq ER 25 mg tablets (30-count) valued at $3,773.91. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by November 5, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's consistent receipt of competitively awarded delivery orders across diverse therapeutic domains demonstrates its established capability to meet federal medical supply requirements efficiently.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 11/4/25 |